|
Myelodysplastic syndromes and the risk of cardiovascular disease in older adults: A SEER-medicare analysis |
Dec 2019 |
Leukemia |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic Syndromes Treatment (PDQ®): Patient Version |
Mar 2019 |
National Cancer Institute |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic syndromes with ring sideroblasts |
Oct 2023 |
Hematological Oncology |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" |
Jan 2021 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
|
Myelodysplastic syndromes with ring sideroblasts (MDS-RS) and MDS/myeloproliferative neoplasm with RS and thrombocytosis (MDS/MPN-RS-T) - "2021 update on diagnosis, risk-stratification, and management" |
Mar 2021 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management |
Nov 2020 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic Syndromes: 2021 update on Diagnosis, Risk-stratification and Management |
Aug 2020 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic syndromes: 2023 update on diagnosis, risk-stratification, and management |
Jun 2023 |
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic Syndromes: A Review of Therapeutic Progress Over the Past 10 Years |
Jun 2020 |
Expert Review of Anticancer Therapy |
Myelodysplastic Syndromes (MDS) |
|
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up |
Nov 2020 |
Annals of Oncology: Official Journal of the European Society for Medical Oncology |
Myelodysplastic Syndromes (MDS) |
